Use of serum markers containing alpha fetal protein (AFP), Golgi protein 73 (GP73) and carcinoembryonic antigen associated cell adhesion molecule 1 (CEACAM1) in diagnosis of liver diseases

作者: Sui Tianqi , Zhang Tao , Lu Ning , Cheng Genhong , Xing Wen

DOI:

关键词:

摘要: The invention relates to use of serum markers containing alpha fetal protein (AFP), Golgi 73 (GP73) and carcinoembryonic antigen associated cell adhesion molecule 1 (CEACAM1) in diagnosis liver diseases. Specifically, the provides reagents an associative part at least one specific binding AFP, GP73 CECAM1 preparation kits for and/or prognosis

参考文章(6)
Gal Markel, Jacob Schachter, Rona Ortenberg, Yair Sapir, Ilana Mandel, Tehila Ben Moshe, Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM) ,(2012)
Yilei Mao, Huayu Yang, Haifeng Xu, Xin Lu, Xinting Sang, Shunda Du, Haitao Zhao, Wang Chen, Yiyao Xu, Tianyi Chi, Zhiying Yang, Jianqiang Cai, Hui Li, Jianguo Chen, Shouxian Zhong, Smruti R Mohanti, Reynold Lopez-Soler, J Michael Millis, Jiefu Huang, Hongbing Zhang, Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma Gut. ,vol. 59, pp. 1687- 1693 ,(2010) , 10.1136/GUT.2010.214916
Edna Meilin, Ilana Mandel, Yair Sapir, Tehila Ben-Moshe, Compositions comprising anti-ceacam1 and anti-pd antibodies for cancer therapy ,(2014)